SCHEMBL14988906

SCHEMBL14988906

CC(=O)Oc1ccccc1C(=O)OCCOC(=O)CCCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.55
HSD17B10 Q99714 3/20 0.51
KDM4E B2RXH2 3/20 0.51
LMNA P02545 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
TDP1 Q9NUW8 4/20 0.50
TSHR P16473 4/20 0.49
ALDH1A1 P00352 3/20 0.49
HPGD P15428 2/20 0.49
ESR1 P03372 1/20 0.49
ITGB3 P05106 1/20 0.49
ITGA2B P08514 1/20 0.49
HMGB1 P09429 1/20 0.49
GGT1 P19440 1/20 0.49
PTGS1 P23219 1/20 0.49
BLM P54132 1/20 0.49
NAPRT Q6XQN6 1/20 0.49
MAPK1 P28482 3/20 0.46
CYP3A4 P08684 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1114384 0.86 PTGS2 (0.57) PTGS2HSD17B10KDM4ELMNACYP1A2
SCHEMBL15048752 0.85 PTGS2 (0.56) PTGS2HSD17B10KDM4ELMNACYP1A2
SCHEMBL11985691 0.84 PTGS2 (0.68) PTGS2HSD17B10KDM4ELMNACYP1A2
SCHEMBL7360282 0.82 KDM4E (0.57) HSD17B10KDM4ETDP1TSHRALDH1A1
SCHEMBL15048758 0.82 PTGS2 (0.43) PTGS2HSD17B10KDM4ELMNACYP1A2
SCHEMBL14988996 0.81 PTGS2 (0.56) PTGS2HSD17B10KDM4ETDP1TSHR
SCHEMBL11985699 0.81 PTGS2 (0.72) PTGS2HSD17B10KDM4ELMNACYP1A2
SCHEMBL27409810 0.81 TDP1 (0.66) KDM4ELMNATDP1ALDH1A1MAPK1
SCHEMBL14997396 0.81 ALDH1A1 (0.54) KDM4ELMNATDP1TSHRALDH1A1
SCHEMBL1114532 0.80 PTGS2 (0.64) PTGS2HSD17B10KDM4ELMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180085333-A1 4-PHENYLBUTYRIC ACID DERIVATIVES TRUOG PETER (CH) 2018-03-29 US disclosed
US-20180085333-A1 4-PHENYLBUTYRIC ACID DERIVATIVES TRUOG PETER (CH) 2018-03-29 US disclosed
WO-2016165770-A1 4-PHENYLBUTYRIC ACID DERIVATIVES TRUOG PETER (CH) 2016-10-20 WO disclosed
EP-2599767-A1 Phenylbutyl-derivatives Lunamed AG (CH) 2013-06-05 EP disclosed
EP-2599767-A1 Phenylbutyl-derivatives Lunamed AG (CH) 2013-06-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180085333-A1 4-PHENYLBUTYRIC ACID DERIVATIVES HTR2B, PAH, HTR1B PTGS2 166/4885HSD17B10 239/4885KDM4E 1574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.